Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1092 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FDA approves Orchid MDD drug

The drug has been given approval for its 37.5mg, 75mg and 150mg dosage strengths. Venlafaxine ER capsules are indicated for the treatment of major depressive disorder (MDD) and

Unilife starts Unifill syringe supply to Sanofi

The Unifill ready-to-fill (prefilled) syringe is a primary drug container with passive safety features fully integrated within the glass barrel. Under the agreement, Unilife has licensed Unifill syringe

O2h widens agreement with Heptares

O2h offers synthetic chemistry, FTE-based medicinal and process chemistry including in-vitro biology services to pharmaceutical and biotechnology companies. Heptares Chemistry head Miles Congreve said O2h has been a

Vela, Protagen sign agreement

Austria-based Vela offers research activities to clinical phases and up to product commercialization to its customers. VELA CEO Markus Fido said their customers will benefit from this alliance

Pfizer to investigate Roslin GMP quality PSC

Under the agreement, the US based pharma firm will evaluate GMP Cell lines of Roslin to assess specific clinical therapies’ potential. Further commercial terms of the agreement are